P-1639

P-1639 is a small molecule inhibitor of the NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) signaling pathway, developed by Aquapharm Biodiscovery. Derived from the company's marine-inspired discovery platform, P-1639 is specifically designed for applications in the personal care and consumer health sectors, targeting inflammatory conditions of the skin and hair. By modulating the NF-κB pathway, which is a central regulator of the immune and inflammatory response, the compound aims to provide therapeutic benefits for various dermatological and trichological concerns. It is currently in the preclinical stage of development.